Norges Bank’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-40,700
| Closed | -$234K | – | 542 |
|
2024
Q4 | $234K | Buy |
+40,700
| New | +$234K | ﹤0.01% | 1823 |
|
2024
Q3 | – | Sell |
-40,700
| Closed | -$528K | – | 555 |
|
2024
Q2 | $528K | Buy |
+40,700
| New | +$528K | ﹤0.01% | 1874 |
|
2023
Q3 | – | Sell |
-150,614
| Closed | -$3.22M | – | 1990 |
|
2023
Q2 | $3.22M | Buy |
150,614
+28,000
| +23% | +$599K | ﹤0.01% | 1809 |
|
2023
Q1 | $4.96M | Sell |
122,614
-103,805
| -46% | -$4.2M | ﹤0.01% | 1760 |
|
2022
Q4 | $10.5M | Buy |
226,419
+66,600
| +42% | +$3.1M | ﹤0.01% | 1553 |
|
2022
Q3 | $8.29M | Buy |
159,819
+20,313
| +15% | +$1.05M | ﹤0.01% | 1599 |
|
2022
Q2 | $6.59M | Hold |
139,506
| – | – | ﹤0.01% | 1697 |
|
2022
Q1 | $9.93M | Buy |
139,506
+15,162
| +12% | +$1.08M | ﹤0.01% | 1703 |
|
2021
Q4 | $9.3M | Buy |
124,344
+14,408
| +13% | +$1.08M | ﹤0.01% | 1785 |
|
2021
Q3 | $6.25M | Hold |
109,936
| – | – | ﹤0.01% | 1891 |
|
2021
Q2 | $4.84M | Sell |
109,936
-18,978
| -15% | -$835K | ﹤0.01% | 1914 |
|
2021
Q1 | $6.36M | Sell |
128,914
-25,088
| -16% | -$1.24M | ﹤0.01% | 1880 |
|
2020
Q4 | $6.48M | Sell |
154,002
-5,692
| -4% | -$240K | ﹤0.01% | 1843 |
|
2020
Q3 | $7.31M | Sell |
159,694
-5,391
| -3% | -$247K | ﹤0.01% | 1800 |
|
2020
Q2 | $8.29M | Sell |
165,085
-46,047
| -22% | -$2.31M | ﹤0.01% | 1768 |
|
2020
Q1 | $10.9M | Hold |
211,132
| – | – | ﹤0.01% | 1575 |
|
2019
Q4 | $13M | Hold |
211,132
| – | – | ﹤0.01% | 1719 |
|
2019
Q3 | $12.7M | Buy |
211,132
+11,986
| +6% | +$720K | ﹤0.01% | 1694 |
|
2019
Q2 | $16.8M | Buy |
199,146
+10,845
| +6% | +$915K | 0.01% | 1597 |
|
2019
Q1 | $18M | Buy |
188,301
+87,975
| +88% | +$8.4M | 0.01% | 1564 |
|
2018
Q4 | $7.11M | Buy |
100,326
+13,078
| +15% | +$926K | ﹤0.01% | 1845 |
|
2018
Q3 | $7.46M | Buy |
+87,248
| New | +$7.46M | ﹤0.01% | 1897 |
|